Cathy Friedman

Insider Reports History

Entity
Individual
Location
C/O Innoviva, Inc., 2000 Sierra Point Parkway, Suite 500, Brisbane, CA
Signature
/s/ Matthew Lang, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cathy Friedman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Director Common Stock 236K $539K $2.28 Jun 14, 2024 MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST
Seer, Inc. Director Class A Common Stock 174K $294K $1.70 Jun 14, 2023 Direct
Lyell Immunopharma, Inc. Director Common Stock 100K $228K $2.28 Jun 14, 2024 The Duane Irrevocable Trust 2020
Lyell Immunopharma, Inc. Director Option (right to buy) 130K Jun 14, 2024 Direct
Seer, Inc. Director Stock Option (right to buy) 34.7K Jun 14, 2023 Direct
Radius Health, Inc. Director Common Stock 0 $10.00 Aug 15, 2022 Direct
Radius Health, Inc. Director Stock Option (Right to Buy) 0 $4.16 Aug 15, 2022 Direct

Insider Reports Filed by Cathy Friedman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
LYEL Lyell Immunopharma, Inc. Sep 8, 2023 1 $0 4 Sep 8, 2023 Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
SEER Seer, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
RDUS Radius Health, Inc. Aug 15, 2022 2 -$304K 4 Aug 15, 2022 Director
SEER Seer, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RDUS Radius Health, Inc. Jan 14, 2022 2 $0 4 Jan 25, 2022 Director
LYEL Lyell Immunopharma, Inc. Dec 14, 2021 2 $0 4 Dec 14, 2021 Director
LYEL Lyell Immunopharma, Inc. Jun 21, 2021 3 $300K 4 Jun 23, 2021 Director
SEER Seer, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director